GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GSK PLC (BSP:G1SK34) » Definitions » Cyclically Adjusted PB Ratio

GSK (BSP:G1SK34) Cyclically Adjusted PB Ratio : 7.35 (As of May. 01, 2024)


View and export this data going back to 2020. Start your Free Trial

What is GSK Cyclically Adjusted PB Ratio?

As of today (2024-05-01), GSK's current share price is R$42.56. GSK's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was R$5.79. GSK's Cyclically Adjusted PB Ratio for today is 7.35.

The historical rank and industry rank for GSK's Cyclically Adjusted PB Ratio or its related term are showing as below:

BSP:G1SK34' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 5.88   Med: 8.05   Max: 12
Current: 7.28

During the past years, GSK's highest Cyclically Adjusted PB Ratio was 12.00. The lowest was 5.88. And the median was 8.05.

BSP:G1SK34's Cyclically Adjusted PB Ratio is ranked worse than
90.41% of 657 companies
in the Drug Manufacturers industry
Industry Median: 1.8 vs BSP:G1SK34: 7.28

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

GSK's adjusted book value per share data for the three months ended in Dec. 2023 was R$20.408. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is R$5.79 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


GSK Cyclically Adjusted PB Ratio Historical Data

The historical data trend for GSK's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GSK Cyclically Adjusted PB Ratio Chart

GSK Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.57 8.29 8.76 6.76 6.31

GSK Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.76 6.59 6.21 6.55 6.31

Competitive Comparison of GSK's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - General subindustry, GSK's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GSK's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GSK's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where GSK's Cyclically Adjusted PB Ratio falls into.



GSK Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

GSK's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=42.56/5.79
=7.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GSK's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, GSK's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=20.408/130.0000*130.0000
=20.408

Current CPI (Dec. 2023) = 130.0000.

GSK Quarterly Data

Book Value per Share CPI Adj_Book
201403 6.635 99.300 8.686
201406 6.023 99.800 7.846
201409 4.949 100.000 6.434
201412 4.530 99.900 5.895
201503 8.968 99.600 11.705
201506 8.491 100.100 11.027
201509 8.404 100.200 10.903
201512 7.626 100.400 9.874
201603 3.796 100.400 4.915
201606 0.716 101.000 0.922
201609 0.151 101.500 0.193
201612 1.198 102.200 1.524
201703 1.693 102.700 2.143
201706 0.870 103.500 1.093
201709 1.382 104.300 1.723
201712 -0.076 105.000 -0.094
201803 -0.080 105.100 -0.099
201806 4.650 105.900 5.708
201809 6.109 106.600 7.450
201812 4.680 107.100 5.681
201903 5.133 107.000 6.236
201906 4.426 107.900 5.333
201909 15.038 108.400 18.035
201912 15.370 108.500 18.416
202003 19.891 108.600 23.811
202006 21.991 108.800 26.276
202009 24.895 109.200 29.637
202012 25.067 109.400 29.787
202103 28.868 109.700 34.210
202106 26.941 111.400 31.439
202109 27.788 112.400 32.139
202112 28.124 114.700 31.876
202203 26.365 116.500 29.420
202206 25.026 120.500 26.999
202209 13.362 122.300 14.203
202212 16.538 125.300 17.158
202303 18.439 126.800 18.904
202306 18.993 129.400 19.081
202309 19.791 130.100 19.776
202312 20.408 130.000 20.408

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


GSK  (BSP:G1SK34) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


GSK Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of GSK's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


GSK (BSP:G1SK34) Business Description

Industry
Address
980 Great West Road, Brentford, Middlesex, GBR, TW8 9GS
In the pharmaceutical industry, GSK ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.

GSK (BSP:G1SK34) Headlines

No Headlines